financial support

Co-Pay Assistance Available

United Therapeutics is pleased to provide financial support in meeting out-of-pocket co-pays for new or existing eligible patients.

United Therapeutics offers financial assistance in meeting your out-of-pocket co-pays. Under this Co-Pay Assistance Program, most eligible patients who enroll pay as little as a $5 co-pay for each prescription. See below for program eligibility requirements.

TO ENROLL IN THIS PROGRAM, PATIENTS MUST UNDERSTAND AND AGREE TO COMPLY WITH THE ELIGIBILITY REQUIREMENTS AND TERMS OF USE.

Eligibility Requirements for this Program are:

  • Patients must be 18 years or older to use this Program
  • The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication
  • Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
  • Eligible patients must be residents of the US or Puerto Rico
  • The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program

Visit www.UTcopay.com for full Program details and Terms and Conditions.

Additional terms and conditions apply

Other financial assistance options may be available if you do not qualify for this Program. Contact ASSIST or visit www.UTassist.com for more information.

You can call 1-877-UNITHER (1-877-864-8437)
Monday through Friday, 8:30 am to 7:00 pm ET
Sign up and share your PAH story

LEARN MORE ABOUT UNITED THERAPEUTICS MEDICINES

EXPAND FOR MORE carrot Img

Treatment options for adult patients with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs.

  • ORENITRAM is a prescription medication shown to delay the progression of PAH and improve your ability to exercise.

  • TYVASO is a prescription medicine that can improve your ability to exercise.

  • REMODULIN is a prescription medicine that can reduce symptoms associated with exercise. In patients who need to switch from epoprostenol, REMODULIN is approved to slow the worsening of symptoms.

What is Orenitram?

Orenitram is a prescription medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of your lungs. Orenitram can help slow down the progression of your disease and improve your ability to exercise. It is not known if Orenitram is safe and effective in children.

IMPORTANT SAFETY INFORMATION FOR ORENITRAM

Who should not take Orenitram?

Do not take Orenitram if you have severe liver problems.

EXPAND FOR MORE carrot Img

Treatment options for adult patients with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs.

  • ORENITRAM is a prescription medication shown to delay the progression of PAH and improve your ability to exercise.

  • TYVASO is a prescription medicine that can improve your ability to exercise.

  • REMODULIN is a prescription medicine that can reduce symptoms associated with exercise. In patients who need to switch from epoprostenol, REMODULIN is approved to slow the worsening of symptoms.

What is Orenitram?

Orenitram is a prescription medicine used to treat pulmonary arterial hypertension (PAH) which is high blood pressure in the arteries of your lungs. Orenitram can help slow down the progression of your disease and improve your ability to exercise. It is not known if Orenitram is safe and effective in children.

IMPORTANT SAFETY INFORMATION FOR ORENITRAM

Who should not take Orenitram?

Do not take Orenitram if you have severe liver problems.